|
Quotes & Info
|
| MKSI > SEC Filings for MKSI > Form 10-Q on 7-Aug-2008 | All Recent SEC Filings |
7-Aug-2008
Quarterly Report
We believe that this Quarterly Report on Form 10-Q contains
"forward-looking statements" within the meaning of the Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act and Section 21E
of the Securities Exchange Act. When used herein, the words "believes,"
"anticipates," "plans," "expects," "estimates," "would," "will," "intends" and
similar expressions are intended to identify forward-looking statements. These
forward-looking statements reflect management's current opinions and are subject
to certain risks and uncertainties that could cause results to differ materially
from those stated or implied. While we may elect to update forward looking
statements at some point in the future, we specifically disclaim any obligation
to do so even if our estimates or expectations change. Risks and uncertainties
include, but are not limited to those discussed in our Annual Report on Form
10-K for the year ended December 31, 2007 in the section entitled "Risk
Factors."
Overview
We are a leading worldwide provider of instruments, components, subsystems
and process control solutions that measure, control, power, monitor and analyze
critical parameters of semiconductor and other advanced manufacturing processes.
We are managed as one operating segment which is organized around three
product groups: Instruments and Control Systems, Power and Reactive Gas Products
and Vacuum Products. Our products are derived from our core competencies in
pressure measurement and control, materials delivery, gas composition analysis,
electrostatic charge management, control and information technology, power and
reactive gas generation and vacuum technology. Our products are used in diverse
markets, applications and processes. Our primary served markets are
manufacturers of capital equipment for semiconductor devices, and for other thin
film applications including flat panel displays, solar cells, data storage media
and other advanced coatings. We also leverage our technology in other markets
with advanced manufacturing applications including medical equipment,
pharmaceutical manufacturing, energy generation and environmental monitoring.
Our customers include manufacturers of semiconductor capital equipment and
semiconductor devices; thin film capital equipment used in the manufacture of
flat panel displays, solar cells, data storage media, and other coating
applications; other industrial, medical and manufacturing companies; and
university, government and industrial research laboratories. For the six months
ended June 30, 2008 and the full year ended December 31, 2007, we estimate that
approximately 61% and 68% of our net revenues, respectively, were to
semiconductor capital equipment manufacturers and semiconductor device
manufacturers. We expect that revenues to the semiconductor capital equipment
manufacturers and semiconductor device manufacturers will continue to account
for a substantial majority of our revenues.
During 2007 and 2008, quarterly revenues ranged from $171.0 million to
$211.4 million. For the third quarter of 2008, we expect that our net revenues
could be slightly below this range. However, the semiconductor capital equipment
industry is subject to rapid demand shifts, which are difficult to predict, and
we are uncertain how long revenue levels may be maintained or the timing or
extent of any future downturn or upturn in the semiconductor capital equipment
industry.
A portion of our net revenues is to operations in international markets.
For the six months ended June 30, 2008 and full year ended December 31, 2007,
international revenues accounted for approximately 39% and 39% of net revenues,
respectively.
Critical Accounting Policies and Estimates
The preparation of our consolidated financial statements and related
disclosures in conformity with accounting principles generally accepted in the
United States of America requires management to make judgments, assumptions and
estimates that affect the amounts reported. There have been no material changes
in our critical accounting policies since December 31, 2007. For further
information, please see the discussion of critical accounting policies in our
Annual Report on Form 10-K for the year ended December 31, 2007 in the section
captioned "Management's Discussion and Analysis of Financial Condition and
Results of Operations - Critical Accounting Policies and Estimates."
Results of Operations
The following table sets forth, for the periods indicated, the percentage
of total net revenues of certain line items included in MKS' consolidated
statements of operations data.
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 2008 2007
Net revenues
Product 86.6 % 91.1 % 87.8 % 91.3 %
Services 13.4 8.9 12.2 8.7
Total net revenues 100.0 100.0 100.0 100.0
Cost of revenues
Cost of product revenues 49.9 52.0 50.2 51.3
Cost of service revenues 8.9 5.8 8.0 5.6
Total cost of revenues 58.8 57.8 58.2 56.9
Gross profit 41.2 42.2 41.8 43.1
Research and development 12.0 9.0 10.9 8.8
Selling, general and administrative 20.5 17.6 18.3 17.0
Amortization of acquired intangible assets 1.2 2.0 1.4 2.0
Income from operations 7.5 13.6 11.2 15.3
Interest income, net 1.0 1.7 1.0 1.7
Impairment of investments (0.1 ) - (0.4 ) -
Income before income taxes 8.4 15.3 11.8 17.0
Provision for income taxes 3.0 4.3 3.7 5.0
Net income 5.4 % 11.0 % 8.1 % 12.0 %
|
Net Revenue (dollars in millions)
Three Months Ended Six Month Ended
June 30, June 30,
2008 2007 % Change 2008 2007 % Change
Net revenues
Product $ 148.1 $ 185.9 (20.4 )% $ 319.8 $ 379.5 (15.7 )%
Service 22.9 18.1 26.9 % 44.6 35.9 24.1 %
Total net revenues $ 171.0 $ 204.0 (16.2 )% $ 364.4 $ 415.4 (12.3 )%
|
Product revenues decreased $37.8 million during the three month period
ended June 30, 2008 mainly due to a decrease in worldwide demand from our
semiconductor capital equipment manufacturer and semiconductor device
manufacturer customers, which resulted in a decrease in revenues of $46.6
million or 36.9% compared to the same period for the prior year. This decrease
was partially offset by an increase in revenues related to other markets, mainly
solar, of $8.8 million or 14.8%.
Product revenues decreased $59.7 million during the six month period ended
June 30, 2008 mainly due to a decrease in worldwide demand from our
semiconductor capital equipment manufacturer and semiconductor device
manufacturer customers, which resulted in a decrease in revenues of $74.5
million or 27.9% compared to the same period for the prior year. This decrease
was partially offset by an increase in revenues related to other markets, mainly
solar, of $14.8 million or 13.2%.
Service revenues consist mainly of fees for services relating to the
maintenance and repair of our products, software maintenance, installation
services and training. Service revenue increased $4.8 million and $8.7 million
during the three and six month periods ended June 30, 2008, respectively, mainly
due to a higher installed base of products and increased software maintenance
fees.
Total international net revenues, including product and service, were
$73.1 million and $143.5 million for the three and six months ended June 30,
2008 or 42.8% and 39.4% of net revenues, respectively, compared to $76.5 million
and $157.6 million for the three and six months ended June 30, 2007 or 37.5% and
37.9% of net revenues, respectively.
Gross Profit
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 % Points Change 2008 2007 % Points Change
Gross profit as
percentage of net
revenues
Product 42.4 % 42.9 % (0.5 )% 42.8 % 43.8 % (1.0 )%
Service 33.4 % 34.8 % (1.4 )% 34.6 % 35.1 % (0.5 )%
Total gross profit
percentage 41.2 % 42.2 % (1.0 )% 41.8 % 43.1 % (1.3 )%
|
Gross profit on product revenues decreased 0.5 percentage points for the
three months ended June 30, 2008 compared to the three months ended June 30,
2007. Our margin was negatively impacted by approximately 3.2 percentage points
from lower revenue volumes and 0.8 percentage points from unfavorable foreign
currency fluctuations, largely offset by 2.7 percentage points from lower
overhead spending and 0.8 percentage points from reduced warranty costs and
favorable product mix.
Gross profit on product revenues decreased by 1.0 percentage point during
the six months ended June 30, 2008 consisting of approximately 2.2 lower
percentage points from decreased revenue volumes and 0.8 percentage point from
unfavorable product mix, partially offset by 2.1 percentage points from lower
overhead spending.
Cost of service revenues consists primarily of costs of providing services
for repair and training which includes salaries and related expenses and other
fixed costs. Service gross profit decreased by 1.4 and 0.5 percentage points for
the three and six month periods ended June 30, 2008, respectively, compared to
the corresponding periods of the prior year, primarily as a result of higher
overhead costs partially offset by increased revenue volumes.
Research and Development (dollars in millions)
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 % Change 2008 2007 % Change
Research and
development expenses $ 20.5 $ 18.4 11.6 % $ 39.7 $ 36.7 8.4 %
|
Research and development expense increased $2.1 million during the three
months ended June 30, 2008 mainly due to increased compensation expense of
$0.8 million, as a result of higher staffing levels, $0.6 million of higher
consultant costs and $0.7 million in other research and development costs,
including patent related costs.
Research and development expense increased $3.1 million during the six
months ended June 30, 2008 mainly due to $1.1 million of higher consultant
costs, increased compensation expense of $1.0 million, as a result of higher
staffing levels and $1.0 million in other research and development costs,
including patent related costs.
Our research and development is primarily focused on developing and
improving our instruments, components, subsystems and process control solutions
to improve process performance and productivity.
We have hundreds of products and our research and development efforts
primarily consist of a large number of projects focused on developing and
improving our instruments, components, subsystems and process control solutions
to improve process performance and productivity, none of which is individually
material to us. Current projects typically have a duration of 12 to 30 months
depending upon whether the product is an enhancement of existing technology or a
new product. Our current initiatives include projects to enhance the performance
characteristics of older products, to develop new products and to integrate
various technologies into subsystems. These projects support in large part the
transition in the semiconductor industry to larger wafer sizes and smaller
integrated circuit geometries, which require more advanced process control
technology. Research and development expenses consist primarily of salaries and
related expenses for personnel engaged in research and development, fees paid to
consultants, material costs for prototypes and other expenses related to the
design, development, testing and enhancement of our products.
We believe that the continued investment in research and development and
ongoing development of new products are essential to the expansion of our
markets, and expect to continue to make significant investment in research and
development activities. We are subject to risks if products are not developed in
a timely manner, due to rapidly changing customer requirements and competitive
threats from other companies and technologies. Our success primarily depends on
our products being designed into new generations of equipment for the
semiconductor industry. We develop products that are technologically advanced so
that they are positioned to be chosen for use in each successive generation of
semiconductor capital equipment. If our products are not chosen to be designed
into our customers' products, our net revenues may be reduced during the
lifespan of those products.
Selling, General and Administrative (dollars in millions)
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 % Change 2008 2007 % Change
Selling, general and
administrative expenses $ 35.1 $ 35.9 (2.3 )% $ 66.8 $ 70.5 (5.2 )%
|
Selling, general and administrative expenses decreased $0.8 million for the
three months ended June 30, 2008 due mainly to a $1.6 million decrease in
consulting costs, primarily related to IT infrastructure, and $0.6 million
decrease in professional fees, partially offset by $0.7 million in foreign
exchange losses and $0.5 million in higher facilities costs.
Selling, general and administrative expenses decreased $3.7 million for the
six months ended June 30, 2008 mainly due to $2.9 million in lower consulting
costs, primarily related to IT infrastructure, a $2.2 million reduction in
foreign exchange as a result of foreign exchange gains of $1.5 million in 2008
compared to foreign exchange losses of $0.7 million in 2007, partially offset by
$0.9 million in higher facility costs. The foreign exchange gains in 2008 were
primarily attributable to the settlement of cash and intercompany loans at
different foreign exchange rates in connection with a legal entity consolidation
in the first quarter between some of our foreign subsidiaries.
Amortization of Acquired Intangible Assets (dollars in millions)
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 % Change 2008 2007 % Change
Amortization of
acquired intangible
assets $ 2.0 $ 4.1 (51.7 )% $ 5.1 $ 8.2 (38.1 )%
|
Amortization expense for the three and six months ended June 30, 2008 decreased $2.1 million and $3.1 million, respectively, as certain acquired intangible assets became fully amortized during 2007 and 2008. Interest Income, Net (dollars in millions)
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 % Change 2008 2007 % Change
Interest income, net $ 1.6 $ 3.6 (54.3 )% $ 3.8 $ 6.9 (44.6 )%
|
Interest income, net decreased $2.0 million and $3.1 million during the
three and six month periods ended June 30, 2008, respectively, mainly as a
result of lower average cash and cash equivalent balances and lower interest
rates in 2008. The lower outstanding cash balances are primarily a result of our
stock repurchase program.
Impairment of Investments (dollars in millions)
Three Months Ended Six Months Ended
June 30, June 30,
2008 2007 % Change 2008 2007 % Change
Impairment of investments $ 0.3 $ - 100 % $ 1.4 $ - 100 %
|
During the fourth quarter of 2007, we determined that declines in the fair
value of our investments in certain commercial paper were other-than-temporary.
This commercial paper was issued by two structured investment vehicles (SIVs)
that entered into receivership during the fourth quarter of 2007 and failed to
make payments at maturity. Due to the mortgage-related assets these issuers
held, they were exposed to the adverse market conditions that affected the value
of their collateral and their ability to access short-term funding. These
investments were not currently trading on active markets, and therefore, had no
readily determinable market value. As a result of our assessment as of
December 31, 2007, we recorded a $1.5 million impairment charge to earnings,
based upon the Company receiving contemporaneous quotes from established
third-party pricing services.
During the three and six months ended June 30, 2008, we determined that
further declines in the value of these two investments were
other-than-temporary. As a result we recorded additional impairment charges of
$0.3 million and $1.4 million, respectively. This resulted in a new cost basis
for these securities of $2.4 million at June 30, 2008.
Provision for Income Taxes (dollars in millions)
Provision for income taxes $ 5.1 $ 8.7 $ 13.5 $ 20.6
Our effective tax rate for the three and six month periods ending June 30,
2008 was 35.4% and 31.4%, respectively. The effective tax rate for the six
months ended June 30, 2008, is less than the statutory tax rate primarily due to
the profits of our international subsidiaries being taxed at rates lower than
the U.S. statutory tax rate.
Our effective tax rate for the three and six month periods ended June 30,
2007 was 27.9% and 29.2%, respectively. The effective tax rate is less than the
statutory tax rate primarily due to the profits of our international
subsidiaries being taxed at rates lower than the U.S. statutory tax rate and the
benefit from U.S. research and development credits.
We adopted FASB Interpretation 48, Accounting for Uncertainty in Income
Taxes ("FIN 48") in 2007. At December 31, 2007, the total amount of gross
unrecognized tax benefits, which excludes interest and penalties discussed
below, was approximately $16.1 million. If these benefits were recognized in a
future period, the timing of which is not estimable, the net unrecognized tax
benefit of approximately $13.2 million would impact the Company's effective tax
rate. The total amount of gross unrecognized tax benefits at June 30, 2008 was
approximately $16.9 million. The increase from January 1, 2008 was primarily
attributable to tax positions taken by the Company in the six months ended
June 30, 2008.
MKS and its subsidiaries are subject to U.S. federal income tax as well as
the income tax of multiple state and foreign jurisdictions. We have concluded
all U.S. federal income tax matters for years through 2002. The 2003 federal tax
year remains open to the extent of the loss carryforward to 2004 and 2005.
Currently the Company is under a federal income tax audit for the 2005 tax year.
As of June 30, 2008, there were ongoing audits in various other tax
jurisdictions. We do not expect any material changes to the returns as filed
from these open audits.
Within the next 12 months, it is reasonably possible that the Company may
recognize $4.5 million to $5.0 million of previously unrecognized tax benefits
related to various federal, state, and foreign tax positions as a result of the
conclusion of various audits and the expiration of the statute of limitations.
The following tax years, in the major tax jurisdictions noted, are open for
assessment or refund: U.S. Federal: 2003 to 2007, Germany: 2001 to 2007, Korea:
2005 to 2007, Japan: 2001 to 2007, and the United Kingdom: 2006 and 2007.
We will accrue interest and, if applicable, penalties, for any uncertain
tax positions. This interest and penalty expense will be a component of income
tax expense. At December 31, 2007 and June 30, 2008, we had $1.5 million and
$1.9 million, respectively, accrued for interest on unrecognized tax benefits.
The U.S. Research and Development Tax Credit expired at the end of 2007 and
to date has not been reinstated. As a result, we did not take any benefit for
this credit in the three and six month periods ending June 30, 2008. The
benefits taken in the three and six month periods ending June 30, 2007 for this
credit were approximately $0.5 million and $0.8 million, respectively.
Liquidity and Capital Resources
Cash, cash equivalents and short-term investments totaled $259.9 million at
June 30, 2008 compared to $323.8 million at December 31, 2007. This decrease was
attributable to our share repurchase program through which we repurchased
$101.9 million of our common stock during the first six months of fiscal 2008.
The primary source of funds for the first six months of fiscal 2008 was cash
provided by operating activities of $42.2 million.
Net cash provided by operating activities of $42.2 million for the six
months ended June 30, 2008, resulted mainly from net income of $29.6 million and
non-cash charges of $12.2 million for depreciation and amortization and
$6.2 million for stock-based compensation and related tax benefits, offset by an
increase in net operating assets of $4.1 million and a decrease in net operating
liabilities of $2.5 million. The $4.1 million increase in operating assets
consisted primarily of a $2.4 million increase in other current assets, mainly
due to increases in value added tax receivables at foreign locations and a
$1.0 million increase in accounts receivable. The net decrease in operating
liabilities is mainly caused by a decrease of $4.4 million in accounts payable
and $2.0 million in income taxes payable, offset by an increase of $3.9 million
in accrued expenses and other liabilities. Net cash provided by operating
activities of $45.2 million for the six months ended June 30, 2007, resulted
mainly from net income of $49.8 million, non-cash charges of $15.4 million for
depreciation and amortization and $8.4 million for stock-based compensation and
related tax benefits, offset by an increase in net operating assets of $21.7
million and an $8.2 million decrease in net operating liabilities. The
$21.7 million increase in net operating assets consisted primarily of a
$14.2 million increase in inventory, to support our then increased revenues and
to support the increased inventory levels required for our planned China
facility
relocation in the second half of 2007, and a $4.8 million increase in other
current assets, primarily related to prepaid taxes. The decrease in net
operating liabilities of $8.2 million is mainly caused by a decrease of
$16.7 million in current income taxes payable, primarily due to payments of
estimated U.S. taxes, offset by an increase of $8.9 million in accrued expenses
and other liabilities.
Net cash provided by investing activities of $4.3 million for the six
months ended June 30, 2008, resulted primarily from net sales of $9.2 million of
available for sale investments, offset by $5.5 million in purchases of property,
plant and equipment. Net cash used in investing activities of $50.4 million for
the six months ended June 30, 2007, resulted primarily from net purchases of
$44.1 million of available for sale investments.
Net cash used in financing activities of $97.5 million for the six months
ended June 30, 2008, consisted primarily of repurchases of common stock of
$101.9 million and $2.6 million in net payments on short-term borrowings, offset
by $6.5 million in proceeds from the exercise of stock options and purchases
under our employee stock purchase plan. Net cash provided by financing
activities of $10.7 million for the six months ended June 30, 2007, consisted
primarily of $39.0 million in proceeds from the exercise of stock options and
purchases under our employee stock purchase plan, offset by repurchases of
common stock of $31.7 million.
On February 12, 2007, our Board of Directors approved a share repurchase
program (the "Program") for the repurchase of up to $300.0 million of our
outstanding stock over two years. The repurchases may be made from time to time
on the open market or through privately negotiated transactions. The timing and
amount of any shares repurchased under the Program will depend on a variety of
factors, including the price of our common stock, corporate and regulatory
requirements, capital availability, and other market conditions. The Program may
be discontinued at any time at the discretion of the Company and our Board of
Directors. During the six months ended June 30, 2008, we repurchased 5.1 million
shares of common stock for $101.9 million for an average price of $20.18 per
share and during the six months ended June 30, 2007, we repurchased 1.2 million
shares of common stock for $31.7 million for an average price of $26.42 per
share.
We believe that our working capital, together with the cash anticipated to
be generated from operations, will be sufficient to satisfy our estimated
working capital, stock repurchase program activity and planned capital
expenditure requirements through at least the next 12 months.
. . .
|
|